Longeveron- Tradeable Rights - August 2023 Receivables

As of the most recent data (June 2026), LGVNR shows a receivables of $65K. That compares with $31K in the prior-year period — up 109.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LGVNR's receivables is now $65K (was $31K) — a 109.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Longeveron- Tradeable Rights - August 2023 is outperforming or lagging.

Tracking LGVNR's receivables over time shows whether Longeveron- Tradeable Rights - August 2023 is scaling, shrinking, or reshaping that part of the business. The current reading is $65K That compares with $31K in the prior-year period — up 109.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Longeveron- Tradeable Rights - August 2023's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $65K) with ownership activity and broader fundamentals.

Longeveron- Tradeable Rights - August 2023's receivables is $65K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.